Although TAL1 and LYL1 are major subtype markers used in clinical T-ALL stratification, cell lines with these markers were not phenotypically distinguished in our clustering relative to other DN or DP cell lines. The gene discussed is LYL1; the disease is acute lymphoblastic leukemia.